263 related articles for article (PubMed ID: 37355940)
21. Nailfold Capillaroscopy - Its Role in Diagnosis and Differential Diagnosis of Microvascular Damage in Systemic Sclerosis.
Lambova S; Hermann W; Muller-Ladner U
Curr Rheumatol Rev; 2013; 9(4):254-60. PubMed ID: 26932290
[TBL] [Abstract][Full Text] [Related]
22. Nailfold videocapillaroscopic patterns and serum autoantibodies in systemic sclerosis.
Cutolo M; Pizzorni C; Tuccio M; Burroni A; Craviotto C; Basso M; Seriolo B; Sulli A
Rheumatology (Oxford); 2004 Jun; 43(6):719-26. PubMed ID: 15026581
[TBL] [Abstract][Full Text] [Related]
23. Absence of Scleroderma pattern at nail fold capillaroscopy valuable in the exclusion of Scleroderma in unselected patients with Raynaud's Phenomenon.
Bissell LA; Abignano G; Emery P; Del Galdo F; Buch MH
BMC Musculoskelet Disord; 2016 Aug; 17(1):342. PubMed ID: 27526772
[TBL] [Abstract][Full Text] [Related]
24. Nailfold capillaroscopy abnormalities correlate with cutaneous and visceral involvement in systemic sclerosis patients.
Sato LT; Kayser C; Andrade LE
Acta Reumatol Port; 2009; 34(2A):219-27. PubMed ID: 19474777
[TBL] [Abstract][Full Text] [Related]
25. Joint contractures responsive to immunosuppressive therapy in a girl with childhood-onset systemic sclerosis double-seropositive for rare anti-nucleolar autoantibodies: a case report.
Tanaka R; Tani Y; Kaburaki Y; Kinoshita M; Kawaguchi Y; Okazaki Y; Kuwana M; Harigai M; Nagata S; Miyamae T
Pediatr Rheumatol Online J; 2021 Mar; 19(1):37. PubMed ID: 33743728
[TBL] [Abstract][Full Text] [Related]
26. Clinical diagnosis compared to classification criteria in in a cohort of 54 patients with systemic sclerosis and associated disorders.
Ziswiler HR; Urech R; Balmer J; Ostensen M; Mierau R; Villiger PM
Swiss Med Wkly; 2007 Oct; 137(41-42):586-90. PubMed ID: 17990152
[TBL] [Abstract][Full Text] [Related]
27. Sex-specific risk of anti-topoisomerase antibodies on mortality and disease severity in systemic sclerosis: 10-year analysis of the Leiden CCISS and EUSTAR cohorts.
Liem SIE; Boonstra M; le Cessie S; Riccardi A; Airo P; Distler O; Matucci-Cerinic M; Caimmi C; Siegert E; Allanore Y; Huizinga TWJ; Toes REM; Scherer HU; de Vries-Bouwstra JK;
Lancet Rheumatol; 2022 Oct; 4(10):e699-e709. PubMed ID: 38265968
[TBL] [Abstract][Full Text] [Related]
28. Progression of patients with Raynaud's phenomenon to systemic sclerosis: a five-year analysis of the European Scleroderma Trial and Research group multicentre, longitudinal registry study for Very Early Diagnosis of Systemic Sclerosis (VEDOSS).
Bellando-Randone S; Del Galdo F; Lepri G; Minier T; Huscher D; Furst DE; Allanore Y; Distler O; Czirják L; Bruni C; Guiducci S; Avouac J; Cutolo M; Smith V; Matucci-Cerinic M;
Lancet Rheumatol; 2021 Dec; 3(12):e834-e843. PubMed ID: 38287630
[TBL] [Abstract][Full Text] [Related]
29. Classification of systemic sclerosis. Visions and reality.
Wollheim FA
Rheumatology (Oxford); 2005 Oct; 44(10):1212-6. PubMed ID: 15870151
[TBL] [Abstract][Full Text] [Related]
30. The Relationship between Smoking, Raynaud's Phenomenon, Digital Ulcers, and Skin Thickness in the Waikato Systemic Sclerosis Cohort.
Silva C; Solanki KK; White DHN
Rheumatol Immunol Res; 2022 Jun; 3(2):84-89. PubMed ID: 36465326
[TBL] [Abstract][Full Text] [Related]
31. Clinical features of Japanese systemic sclerosis (SSc) patients negative for SSc-related autoantibodies: A single-center retrospective study.
Miyake M; Matsushita T; Takehara K; Hamaguchi Y
Int J Rheum Dis; 2020 Aug; 23(9):1219-1225. PubMed ID: 32662135
[TBL] [Abstract][Full Text] [Related]
32. Interstitial lung disease in systemic sclerosis: data from the spanish scleroderma study group.
Sánchez-Cano D; Ortego-Centeno N; Callejas JL; Fonollosa Plá V; Ríos-Fernández R; Tolosa-Vilella C; Espinosa-Garriga G; Colunga-Argüelles D; Egurbide-Arberas MV; Rubio-Rivas M; Freire M; Ríos-Blanco JJ; Trapiella-Martínez L; Rodríguez-Carballeira M; Marín-Ballvé A; Pla-Salas X; Simeón-Aznar CP
Rheumatol Int; 2018 Mar; 38(3):363-374. PubMed ID: 29322341
[TBL] [Abstract][Full Text] [Related]
33. State-of-the-art technologies provide new insights linking skin and blood vessel abnormalities in SSc-related disorders.
Dinsdale G; Wilkinson S; Wilkinson J; Moore TL; Manning JB; Berks M; Marjanovic E; Dickinson M; Herrick AL; Murray AK
Microvasc Res; 2020 Jul; 130():104006. PubMed ID: 32320708
[TBL] [Abstract][Full Text] [Related]
34. A subset of systemic sclerosis but not of systemic lupus erythematosus is defined by isolated anti-Ku autoantibodies.
Cavazzana I; Fredi M; Taraborelli M; Quinzanini M; Tincani A; Franceschini F
Clin Exp Rheumatol; 2013; 31(2 Suppl 76):118-21. PubMed ID: 23910615
[TBL] [Abstract][Full Text] [Related]
35. [Autoantibodies in systemic sclerosis and their clinical correlation in patients from a Midwestern region of Brazil].
Coelho Horimoto AM; da Costa IP
Rev Bras Reumatol; 2015; 55(3):229-39. PubMed ID: 25559063
[TBL] [Abstract][Full Text] [Related]
36. Registry of the Spanish network for systemic sclerosis: clinical pattern according to cutaneous subsets and immunological status.
Simeón-Aznar CP; Fonollosa-Plá V; Tolosa-Vilella C; Espinosa-Garriga G; Ramos-Casals M; Campillo-Grau M; García-Hernández FJ; Castillo-Palma MJ; Sánchez-Román J; Callejas-Rubio JL; Ortego-Centeno N; Egurbide-Arberas MV; Trapiellla-Martínez L; Gallego-Villalobos M; Sáez-Comet L; Velilla-Marco J; Camps-García MT; de Ramón-Garrido E; Esteban Marcos EM; Pallarés-Ferreres L; Hidalgo-Tenorio C; Sabio-Sánchez JM; Gómez-de la Torre R; Salvador-Cervello G; Rios-Blanco JJ; Gil-Aguado A; Vilardell-Tarrés M
Semin Arthritis Rheum; 2012 Jun; 41(6):789-800. PubMed ID: 22169458
[TBL] [Abstract][Full Text] [Related]
37. Mucocutaneous and demographic features of systemic sclerosis: a profile of 46 patients from eastern India.
Ghosh SK; Bandyopadhyay D; Saha I; Barua JK
Indian J Dermatol; 2012 May; 57(3):201-5. PubMed ID: 22707772
[TBL] [Abstract][Full Text] [Related]
38. Correlations between skin blood perfusion values and nailfold capillaroscopy scores in systemic sclerosis patients.
Ruaro B; Sulli A; Pizzorni C; Paolino S; Smith V; Cutolo M
Microvasc Res; 2016 May; 105():119-24. PubMed ID: 26907637
[TBL] [Abstract][Full Text] [Related]
39. Serological profile of patients with systemic sclerosis.
Wielosz E; Dryglewska M; Majdan M
Postepy Hig Med Dosw (Online); 2014 Aug; 68():987-91. PubMed ID: 25228505
[TBL] [Abstract][Full Text] [Related]
40. [Clinical features of systemic sclerosis and association with antitopoisomerase-1 antibody and centromere pattern of antinuclear antibody].
Bertazzi GR; de Toledo RA; de Godoy MF; Geraldino GC; Polizelli DV; Fernandes GC; Pedroso CL; dos Santos FG; de Assis TM
Acta Reumatol Port; 2012; 37(1):9-17. PubMed ID: 22781510
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
